Goldiam International Reports Appropriate QIP Fund Utilization in Q3FY26 Monitoring Report

2 min read     Updated on 10 Feb 2026, 12:13 AM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Goldiam International Limited received a positive monitoring report from CARE Ratings for Q3FY26, confirming appropriate utilization of its Rs. 202.05 crore QIP proceeds. The company has utilized Rs. 18.08 crore cumulatively for store expansion, with Rs. 183.97 crore unutilized funds strategically invested in NCDs, fixed deposits, and alternative funds. Progress includes opening 13 new stores with 19 more planned, advancing toward the target of 63 brand-exclusive stores across India.

32208200

*this image is generated using AI for illustrative purposes only.

Goldiam International Limited has successfully passed its quarterly monitoring review for the utilization of proceeds from its Rs. 202.05 crore Qualified Institutional Placement (QIP), according to a report issued by CARE Ratings Limited for the quarter ended December 31, 2025.

QIP Utilization Overview

The monitoring agency confirmed that all proceeds utilized during Q3FY26 were in accordance with disclosures made in the placement document. The company has maintained transparency in fund deployment while ensuring optimal returns on unutilized amounts.

Parameter Amount (Rs. Crore)
Total QIP Size 202.05
Cumulative Utilization 18.08
Unutilized Proceeds 183.97
Quarterly Utilization (Q3FY26) 6.46

Fund Deployment Progress

The primary objective of the QIP is funding expenditure towards setting up 63 new brand-exclusive stores across India, with a total allocation of Rs. 194.96 crore. During Q3FY26, the company made significant progress in this initiative.

Store Expansion Activities

Category Allocation (Rs. Crore) Utilized (Rs. Crore) Remaining (Rs. Crore)
Inventory 162.50 9.39 153.11
Civil & Interior Works 32.46 4.05 28.41
Issue Expenses 6.84 4.64 2.20
General Corporate Purpose 0.25 - 0.25

The company has opened 13 new retail stores till January 07, 2026, and signed MoUs for 19 additional stores planned for the coming months, progressing toward its target of 63 stores.

Investment of Unutilized Proceeds

CARE Ratings noted that Rs. 183.97 crore of unutilized proceeds have been strategically invested across various instruments to generate returns while maintaining liquidity for future deployment.

Investment Portfolio Breakdown

Investment Type Amount (Rs. Crore) Key Details
Non-Convertible Debentures 55.60 Various maturities from 2026-2027
Fixed Deposits with NBFCs 42.50 Returns ranging 6.50%-6.79%
Fixed Deposits with Banks 75.50 Kotak Mahindra Bank at 4.55%
Alternative Investment Funds 9.50 Neo Asset Management Yield Enhancer
Monitoring Account Balance 0.87 Liquid funds

Regulatory Compliance and Approvals

The monitoring report confirmed that the company has obtained all necessary government and statutory approvals related to the project objectives. Board resolution dated August 11, 2025, authorized the management to invest unutilized QIP proceeds in creditworthy instruments until required for deployment.

Risk Factors and Market Considerations

CATE Ratings highlighted that the company derived approximately 99% of its sales in FY25 from exports, with the US contributing more than 95% of revenue. The monitoring agency noted that potential imposition of additional import tariffs on India could impact the company's performance in coming quarters.

The report also mentioned that Rs. 29.43 crore of unutilized proceeds have been invested in non-convertible debentures with maturities extending beyond the timeline specified in the placement document, though the company clarified these are listed instruments that can be liquidated within 2-3 working days.

Implementation Timeline

According to the placement document, the company plans to deploy Rs. 85.19 crore by March 31, 2026, and Rs. 110.01 crore by March 31, 2027. As of December 31, 2025, Rs. 13.44 crore has been utilized against the first milestone, indicating steady progress toward the implementation schedule.

The monitoring report found no deviations from the stated objectives and confirmed that shareholder approval requirements were not applicable as no material deviations occurred during the quarter.

Source: Exclusive

Historical Stock Returns for Goldiam International

1 Day5 Days1 Month6 Months1 Year5 Years
+1.60%-5.10%-21.78%-25.71%-28.85%+319.17%
like15
dislike

Goldiam International Announces Rs 80 Crore Export Orders for Lab-Grown Diamond Jewellery

1 min read     Updated on 04 Feb 2026, 01:53 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Goldiam International Ltd has secured export orders worth Rs 80 crores for lab-grown diamond jewellery from USA and Middle East clients. The orders involve manufacturing and export of lab-grown diamond studded gold jewellery, to be executed by April 30, 2026. The company disclosed that these figures exclude online orders, indicating additional business beyond the announced contracts, providing strong momentum for the near term.

31739008

*this image is generated using AI for illustrative purposes only.

Goldiam international has announced securing significant export orders worth Rs 80 crores for manufacturing and export of lab-grown diamond jewellery. The Mumbai-based manufacturer and exporter disclosed this development under Regulation 30 of SEBI (LODR) Regulations, 2015, highlighting the company's expanding international presence in the lab-grown diamond segment.

Order Details and Timeline

The export orders have been awarded by international clients from the USA and Middle East markets. The company expects to fulfill these orders on or before April 30, 2026, ensuring strong business momentum in the near term. Notably, the disclosed figure of Rs 80 crores does not include the company's online orders, suggesting additional revenue streams beyond these contracted exports.

Parameter Details
Order Value Rs 80 crores
Client Base International USA & Middle East clients
Product Type Lab-grown diamond studded gold jewellery
Execution Timeline On or before April 30, 2026
Order Classification International export orders

Product Focus and Market Positioning

The orders specifically involve lab-grown diamond studded gold jewellery, reflecting the growing global demand for sustainable and ethically sourced diamond alternatives. This development positions Goldiam International strategically in the expanding lab-grown diamond market, particularly in key international markets including the USA and Middle East regions.

Regulatory Compliance and Transparency

In compliance with SEBI regulations, Goldiam International confirmed that the promoter group has no interest in the entities awarding these orders, and the contracts do not fall under related party transactions. This ensures arms-length dealings and maintains transparency in the company's business operations.

Business Impact

The Rs 80 crore order book represents a substantial business development for Goldiam International, demonstrating the company's capability to secure large-scale international contracts in the competitive jewellery export market. The focus on lab-grown diamonds aligns with global trends toward sustainable luxury products, potentially opening additional market opportunities for the company.

Historical Stock Returns for Goldiam International

1 Day5 Days1 Month6 Months1 Year5 Years
+1.60%-5.10%-21.78%-25.71%-28.85%+319.17%
like19
dislike

More News on Goldiam International

1 Year Returns:-28.85%